Investing in the future of healthcare

Health and physician system leaders are facing unprecedented challenges while operating in an ever-evolving healthcare landscape. The Labcorp Venture Fund invests in early-stage private companies operating in strategic or adjacent spaces to develop novel solutions to important problems in health and healthcare.

Read more »
<span>Labcorp opens new Los Angeles based laboratory</span>
December 8, 2022

Labcorp opens new Los Angeles based laboratory

New Space Will Be Three Times Larger and Increase Testing Capabilities BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 8, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has begun operations at a new, larger anatomic pathology and histology (APH) laboratory in
Read more »

The Clinical Relevance of Anti-DFS70 Autoantibodies

Presentation on the use of the anti-DFS70 antibodies to help identify ANA-positive individuals who do not have an ANA-associated autoimmune disease (AARD), especially in the absence of significant clinical findings.

Speaker

Vincent Ricchiuti, PhD Laboratory Director and Discipline Director in Immunology, Labcorp

Webinars

Cases in Biologic and other Specialized Therapeutic Drug Monitoring

Presentation on the use of traditional and biologic therapeutic drug monitoring to help physicians optimize the management of rheumatic disorders.

Speaker

Jane Yang, MD, Medical Science Director, Labcorp

Webinars